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1 Glossary of Terms: Vision Screening 
Abnormal test result A デWゲデ ヴWゲ┌ﾉデ ┘ｴWヴW ; ﾐﾗヴﾏ;ﾉ さヮ;ゲゲざ ヴWゲヮﾗﾐゲW Iﾗ┌ﾉS ﾐﾗデ HW 
detected under good conditions. The result on screening 
equipmWﾐデ ﾏ;┞ ｷﾐSｷI;デW さﾐﾗ ヴWゲヮﾗﾐゲWがざ さa;ｷﾉがざ ﾗヴ さヴWaWヴくざ 
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
 Invited for screening includes all those that are offered 
the screening test. 
 Tested and receive a result could be a ╉pass╊ or ╉referral to diagnostic assessment╊┻ 
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
 Eligible for screening includes those within the 
population that are covered under the screening or 
health care programme. 
 Tested and receive a result could be a ╉pass╊ or ╉refer 
to diagnostic assessment╊┻ 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
デ;ヴｪWデ IﾗﾐSｷデｷﾗﾐぶ デｴ;デ ヴWIWｷ┗W ; ヴWゲ┌ﾉデ ﾗa さヮ;ゲゲざ S┌ヴｷﾐｪ ゲIヴWWﾐｷﾐｪく 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
A デWゲデ ヴWゲ┌ﾉデ ┘ｴWヴW ; ﾐﾗヴﾏ;ﾉ さヮ;ゲゲざ ヴWゲヮﾗﾐゲW Iﾗ┌ﾉS ﾐﾗデ HW 
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
 
  




ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
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3 Population and Healthcare Overview 
The population of Germany is 82,695,000 (World Bank, 2018a) and the birth rate is 
estimated at 9.3 births/1,000 population in 2016 (World Bank, 2018b). The change in 
population and birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B 
respectively. 
Germany has a reported population density of 237 people per square kilometre in 2017 and 
this has risen from 210 people per square kilometre in 1961 (World Bank, 2018c). Infant 
mortality in 2017 is estimated at 3.1 deaths/1,000 live births in total (World Bank, 2018d). 
The average life expectancy in Germany is estimated at 80.6 years (World Bank, 2018e), with 
a death rate of 11.2 deaths/1,000 population in 2016 (World Bank, 2018f). Germany has a 
gross national income per capita (PPP int. $, 2013) of $44,000 (WHO, 2016). The estimated 
total expenditure on health per capita in 2014 was $5,182 (Intl $) and the total expenditure 













Figure 1: Change in the Total Population and Birth Rate in Germany between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 




4 Vision Screening Commissioning and Guidance 
In Germany, vision screening is embedded into a general preventative child healthcare 
screening system and is organised nationally, with no regional variation in vision screening. 
There are however, regional differences between paediatricians in relation to amblyopia 
screening (refraction measurement) for children aged up to 2 years. These differences depend 
on the type of health insurance individuals have; some reimburse the cost of screening, some 
do not. Some insurance covers a refraction examination at age 2 to 3 years.  Approximately 
10% of the general population of Germany have some form of private health insurance. 
Refraction screening is offered by some statutory and some private health insurances. In all 
regions of Germany vision screening is funded by the state for general health screening, but 
parents can opt to pay for additional screening, or if they are covered by private health 
insurance, they can attend vision screening through this. For example, refraction 
measurement is not part of the general vision screening in Germany, which is funded by the 
state (statutory and private health insurances have to pay for the general vision screening). 
The vision screening programme started in the 1970s and the content was decided upon by 
the national government. The vision screening programme was changed in July 2008, 
whereby a visual acuity test was added as part of the general child healthcare examinations 
at the age of 3 years. There is no clear process in place to determine how often and the 
procedure adopted for revisions to the vision screening programme.  
There are national general health screening guidelines, but no specific vision screening 
guidelines are available. There are no methods for quality monitoring imposed by the 
government. There has been research concerning vision screening in Germany, as part of 
health service research. Studies have been conducted to evaluate the outcome of vision 
screening; some of these studies are discussed in sections 6 of this report. Cost-effectiveness 
has been investigated by Gandjour et al (2003) which suggested that in Germany, both from 
a cost-effectiveness and clinical-effectiveness point of view, screening all children, up to the 
age of 1 year, for amblyopia and amylogenic factors, should be conducted by an 
ophthalmologist. However, the full text research article is not accessible, therefore all cost 
information in section 9 has been provided by the country representative.  
Vision screening is conducted by paediatricians, medical assistants and nurses. Vision 
screening at the school entry examination is conducted by medical assistants, of which there 
are approximately 780 per million overall population. There are 179 paediatricians per million 
population and 12 physicians, however, this is overall and they are not just employed for 
vision screening. Nurses and practice assistants perform most screening, as delegated by the 
paediatrician. There is no specific training to perform vision screening.  




5 Screening programme  
The target conditions screened for by vision screening are retinopathy of prematurity (ROP), 
congenital eye disorders and reduced visual acuity. The health care professionals delivering 
vision screening, venue for screening and tests used vary depending on the age of the child 
as shown in Tables 1, 2 and 3 respectively. Specific details of the screening offered within each 
age group are described more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened by either an ophthalmologist or 
paediatrician in a hospital (during their hospital stay) and then at a private practice. The tests 
conducted at this age include eye inspection, red reflex testing and retinal examination. 
Preterm babies below 1500g and below 32 weeks of gestational age receive a retinal 
examination every two weeks (if nothing is found), until they reach normal birth term, in 
addition to this, they receive eye inspection and red reflex tests at days 3 to 10 and weeks 4 
to 5.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by a paediatrician in private 
practice. The tests conducted at this age include eye inspection and red reflex testing. These 
tests are conducted at 3 to 10 days and 3 months (eye inspection) and 4 weeks to 3 months 
(red reflex test). Babies are referred to an ophthalmologist for further diagnostic examination 
after the first abnormal test, there is no protocol for how many inconclusive tests determine 
referral for further examination.  
5.3 Vision screening - 3 months to 36 months 
Infants aged 3 to 36 months of age are screened by a paediatrician in private practice. The 
tests conducted at this age are eye inspection, fixation, red reflex testing, pursuit movements 
and pupillary reflexes and autorefraction (Rodenstock Vision Tester-R11 or R2). The tests 
performed at each age are:  
Ɣ 3 to 4 months of age - eye inspection, red reflex testing and fixation 
Ɣ 6 months - eye inspection, red reflex testing, fixation, pursuit movements 
Ɣ 1 year - eye inspection, red reflex testing, fixation, pursuit movements, pupillary 
reflexes 
Ɣ 2 years - eye inspection, red reflex testing, pupillary reflexes 
 
If a child is on private health coverage and in some health insurances, automated screening 
(PlusOptix) can be conducted at age 1 year and 3 years. One abnormal test determines 
referral to an ophthalmologist for further examination.  




5.4 Vision screening - 36 months to 7 years 
Children aged 36 months up to 7 years are screened by a paediatrician in private practice. The 
tests conducted at this age include eye inspection, Hirschberg test, pupillary reflexes, visual 
acuity measurement and stereopsis (Lang Test). Tests are conducted at 4 years of age, 5 years 
of age and by a nurse under the guidance of a paediatrician before entering school at 6 years 
of age. Visual acuity is measured at all ages by a paediatrician or the medical assistant under 
supervision of the paediatrician. The Löhlein chart is the most commonly used chart, although 
there are no specific guidelines detailing the use of this. The Löhlein chart is based on the 
Snellen principle, but optotypes are presented. The optotypes sizes and visual acuity ranges 
from 0.2 to 1.0 decimal (0.7 to 0.0 logMAR, 6/30 to 6/6 Snellen). There are no formal defined 
referral criteria per age category. One abnormal test determines referral to an 















Table 1: Healthcare professionals who conduct vision screening in each age group   
Table 1 
Ophthalmologist Paediatrician Medical Assistant 
Under supervision of 
paediatrician 
Nurse 
Under supervision of 
paediatrician 
Preterm babies    × × 
0 to 3 months  ×  × × 
3 to 36 months  ×  × × 
3 to 7 years  ×    
 
  




Table 2: Vision screening tests used in vision screening for each age group  
Table 2 





 ×   × × × × × × × 
0 to 3 months   ×  × × × × × × × × 
3 to 36 months     × ×   × ×   
3 to 7 years   × × ×  ×    ×  
Key: EI: Eye Inspection; Fix: Fixation; RR: Red Reflex Testing; Hir: Hirschberg; RE: Retinal Examination; PM: Pursuit Movements; PR: Pupillary 
Reflexes; VA: Visual Acuity Measurement; SV: Stereopsis; AR: Autorefraction; AS: Automated Screening 
  




Table 3: Location of vision screening for each age group  
Table 3 
Hospital Private Practice 
Preterm babies    
0 to 3 months  ×  
3 to 36 months  ×  
3 to 7 years  ×  
 




6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results of refraction 
and is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss. In Germany, the automated screening devices used include, most commonly, 
PlusOptix.  It is not known how much these devices cost, the maintenance costs per year, or 
after how many years they are scheduled to be replaced. 
It is not known how many of these areas are conducting automated screening. The age at 
which it is used depends on the health insurance and whether or not the cost of this is 
reimbursed. The Rodenstock Vision Tester device is presumed to be widely used in Germany, 
as it is used in the preschool health examination vision testing. In general, visual acuity is 
tested alongside autorefraction, however, in younger children (preschool) visual acuity is not 
included. It is not known if this is used on all children, or just a selected group where visual 
acuity is borderline or failed.  
The referral criteria depend on age; the current cut-off values are: up to the age of 90 months: 
anisometropia >=1.0 Dioptres. It is not known if a child is still referred if he/she passes the 
visual acuity test, but fails autorefraction. There is no comparative data between areas the do 

















7 Provision for Visually Impaired  
In Germany, there are 74 registered schools for blind or severely visually impaired children  
with 4,615 children attending these schools. The costs per child for these school is not known. 
There is special support for visually impaired children who attend regular mainstream primary 
school, howeverが デｴｷゲ SWヮWﾐSゲ ﾗﾐ デｴW ﾉﾗI;ﾉ ゲｷデ┌;デｷﾗﾐゲ ;ﾐS デｴW ｷﾐデWｪヴ;デｷﾗﾐ ﾗa デｴW 
ｴW;Sﾏ;ゲデWヴっデW;IｴWヴゲく TｴWヴW ;ヴW ﾐﾗ ﾉWｪ;ﾉ IヴｷデWヴｷ; aﾗヴ ゲヮWIｷ;ﾉ ゲ┌ヮヮﾗヴデ ﾗaaWヴWS デﾗ デｴWﾏ ;ﾐS デｴW 

























8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
There is no countrywide data concerning the prevalence of treated or untreated amblyopia 
at age 7 years. The prevalence of persistent amblyopia (missed by screening or failed 
treatment) at age 7 years is unknown. However, a study by Elflein et al (2015) found a 
prevalence of 5.6% in adults age 35-44 years. This was based on a population of 3227 
participants from the city of Mainz and the Mainz-Bingen area. A questionnaire issued to 
17,640 parents of children and adolescents aged up to 17 years living in Germany found the 
reported prevalence of strabismus to be 4.1%. (Schuster et al, 2017). In this study, prevalence 
was further stratified by age:  
Ɣ 0-1 years: 2.6% に Confidence Interval (CI): 1.8-3.6 
Ɣ 2-3 years: 2.3% に CI: 1.6 to 3.5 
Ɣ 4-5 years: 3.3% に CI: 2.5 to 4.3 
Ɣ 6-7 years: 4.1% に CI: 3.2 to 5.2 
 
There is no available evidence pertaining to the incidence of the four types of amblyopia 
(strabismic, refractive, combined mechanism and deprivation).  
8.2 Coverage 
All children are invited for vision screening as part of the general screening. Children are sent 
a letter and invited by the state for general preventative child healthcare screening. There is 
no national data on coverage of vision screening.  A study by Kamtruiris et al (2007) carried 
out a retrospective survey to determine the uptake of child screening examinations. 
Participants consisted of 17,641 parents of children and adolescents up to age 17 years. The 
results indicated that up to 3-years of age) 90% attended the screening, however this 
decreased to 89.0% at 4-years of age, and 86.4% for screening offered at 5 years of age 
8.3 Screening evaluation 
There is currently no data available concerning the percentage of false negative screening 
results, false positive screening results, the positive predictive vaﾉ┌W ﾗa ; けヴWaWヴげ ヴWゲ┌ﾉデが デｴW 
sensitivity, or specificity of vision screening in Germany.  
8.4 Treatment success 
There is no available data regarding the percentage of infants treated for congenital eye 
disorders in the total population. The percentage of children treated for strabismus, after 
being screened before the age of seven is unknown, however Schuster et al (2017) report that 
5% of children have strabismus in Germany (Baseline survey 2003 to 2006; N=17,640; 0-17 
years of age). The percentage of all children treated for strabismus before the age of 7 years 




in unknown. The percentage of children treated for amblyopia, after being screened before 
the age of 7 years, is not known. The percentage of all children treated for amblyopia is also 
not known. There is no registration or documentation of noncompliance with referral after 
an abnormal screening test result. It is estimated that 750 patients have childhood cataract 
surgery and undergo surgery each year throughout the country. 
Ophthalmologists are the only professionals who prescribe glasses to children under the age 
of 7 years, after referral from vision screening. Other treatment options include patching, 






















9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs per year for vision screening professionals is not known. However, the salary 
costs per hour for screening professionals is estimated at 41.79 Euros for each child 
healthcare examination lasting approximately 30 minutes: 21 Euros of which is reflective of 
the time take for the vision screening. It is estimated that it costs approximately 110,000 
Euros to train a paediatrician, between leaving secondary education to qualification. The total 
screening costs per year are not available. The total costs per child, per year, for vision 
screening nationally are estimated at: 
Ɣ Amblyopia screening (PlusOptix) when carried out at age 1 year and age 3 years = 25 
Euros  
Ɣ Vision screening as part of the general health examination carried out at age 3 years, 
4 years and 5 years of age and vision screening at school entry health examination = 
13.50 Euros 
9.2 Cost of treatment for amblyopia 
The estimated total costs of treatment for typical patients with refractive amblyopia and 
strabismic amblyopia, including follow up are 1,440 Euros:  
Ɣ cost of visits: 30 Euros at 2 per year, over 4 years = 240 Euros  
Ɣ cost for glasses: 200 Euro per year (estimation) x 4 years = 800 Euros 
Ɣ cost for patching: 100 Euro per year (estimation) x 4 years = 400 Euros 
9.3 Cost of Treatment for strabismus  
 The estimated costs of strabismus surgery, including follow up are not known.  
9.4 Cost of treatment for cataract 
The estimated costs of congenital cataracts surgery, including follow up of deprivation 
amblyopia are 6,000 Euros:  
Ɣ cataract surgery 2x approximately (2,000 Euros) 
Ɣ ophthalmologist appointments: 20 visits at 30 Euros each visit, patching 400 Euros, 
glasses/contact lenses 1000 Euros 
Vision screening is mostly covered by health insurance, some paediatricians offer uncovered 
PlusOptix screening for amblyopia, parents can choose to pay for this (25 Euros). There is no 
financial reward for attending vision screening and no penalty for non-attendance. Vision 
screening is obligatory and enforced through school entry screening and the national child 
healthcare screening system.  





EﾉaﾉWｷﾐが Hくが FヴWゲWﾐｷ┌ゲが “くが L;ﾏヮ;ヴデWヴが Jくが Pｷデ┣が “くが PaWｷaaWヴが Nくが BｷﾐSWヴが Hくが WｷﾉSが Pく ;ﾐS Mｷヴゲｴ;ｴｷが Aく 
ふヲヰヱヵぶく TｴW PヴW┗;ﾉWﾐIW ﾗa AﾏHﾉ┞ﾗヮｷ; ｷﾐ GWヴﾏ;ﾐ┞ぎ D;デ; aヴﾗﾏ デｴW ヮヴﾗゲヮWIデｷ┗WどH;ゲWS G┌デWﾐHWヴｪ 
ｴW;ﾉデｴ ゲデ┌S┞く DW┌デゲIｴWゲ Aヴ┣デWHﾉ;デデ IﾐデWヴﾐ;デｷﾗﾐ;ﾉが ヱヱヲぎンンΒどヴヴ 
G;ﾐSﾃﾗ┌ヴが Aくが “IｴﾉｷIｴデｴWヴﾉWが “くが NW┌ｪWH;┌Wヴが Aくが ‘Üゲゲﾏ;ﾐﾐが Wく ;ﾐS WｷﾉｴWﾉﾏ L;┌デWヴH;Iｴが Kく 
ふヲヰヰンぶく A CﾗゲデどEaaWIデｷ┗WﾐWゲゲ MﾗSWﾉ ﾗa “IヴWWﾐｷﾐｪ “デヴ;デWｪｷWゲ aﾗヴ AﾏHﾉ┞ﾗヮｷ; ;ﾐS ‘ｷゲﾆ F;Iデﾗヴゲ ;ﾐS 
Iデゲ AヮヮﾉｷI;デｷﾗﾐ ｷﾐ ; GWヴﾏ;ﾐ “Wデデｷﾐｪく OヮデﾗﾏWデヴ┞ ;ﾐS Vｷゲｷﾗﾐ SIｷWﾐIWが Βヰふンぶが ヮヮくヲヵΓどヲヶΓく 
K;ﾏデゲｷ┌ヴｷゲが Pくが BWヴｪﾏ;ﾐﾐが Eくが ‘;デデ;┞が Pくが “Iｴﾉ;┌Sが Mく ふヲヰヰΑぶく UゲW ﾗa ﾏWSｷI;ﾉ ゲWヴ┗ｷIWゲぎ ‘Wゲ┌ﾉデゲ ﾗa 
デｴW IｴｷﾉS ;ﾐS Yﾗ┌デｴ HW;ﾉデｴ “┌ヴ┗W┞ ふKｷGG“ぶく FWSWヴ;ﾉ HW;ﾉデｴ G;┣WデデWが HW;ﾉデｴ ‘WゲW;ヴIｴが HW;ﾉデｴ 
PヴﾗデWIデｷﾗﾐが ヵヰふヵどヶぶが ヮヮくΒンヶどΒヵヰく  
K@ゲﾏ;ﾐﾐどKWﾉﾉﾐWヴが Bくが HWｷﾐWが Mくが Pa;┌が Bくが “ｷﾐｪWヴが Aく ;ﾐS ‘┌ヮヴWIｴデが Kく ふヱΓΓΒぶく “IヴWWﾐｷﾐｪど
UﾐデWヴゲ┌Iｴ┌ﾐｪ ;┌a AﾏHﾉ┞ﾗヮｷWが “デヴ;Hｷゲﾏ┌ゲ ┌ﾐS ‘Waヴ;ﾆデｷﾗﾐゲ;ﾐﾗﾏ;ﾉｷW HWｷ ヱヰンヰ 
KｷﾐSWヴｪ;ヴデWﾐﾆｷﾐSWヴﾐく KﾉｷﾐｷゲIｴW Mﾗﾐ;デゲHﾉ@デデWヴ a┑ヴ A┌ｪWﾐｴWｷﾉﾆ┌ﾐSWが ヲヱンふヰΓぶが ヮヮくヱヶヶどヱΑンく  
“Iｴ┌ゲデWヴ AKが EﾉaﾉWｷﾐ HMが Pﾗﾆﾗヴ; ‘が UヴゲIｴｷデ┣ M“く CｴｷﾉS ゲデヴ;Hｷゲﾏ┌ゲ ｷﾐ GWヴﾏ;ﾐ┞ぎ PヴW┗;ﾉWﾐIW ;ﾐS 
ヴｷゲﾆ ｪヴﾗ┌ヮゲく ‘Wゲ┌ﾉデゲ ﾗa デｴW KｷGG“ ゲデ┌S┞く FWSWヴ;ﾉ HW;ﾉデｴ G;┣WデデWが HW;ﾉデｴ ‘WゲW;ヴIｴが HW;ﾉデｴ 
PヴﾗデWIデｷﾗﾐく ヲヰヱΑ A┌ｪきヶヰふΒぶぎΒヴΓどΒヵヵく 
TｴW WﾗヴﾉS B;ﾐﾆ ふヲヰヱΒ;ぶく Pﾗヮ┌ﾉ;デｷﾗﾐが デﾗデ;ﾉ づ D;デ;く ぷﾗﾐﾉｷﾐWへ A┗;ｷﾉ;HﾉW ;デぎ 
ｴデデヮゲぎっっS;デ;く┘ﾗヴﾉSH;ﾐﾆくﾗヴｪっｷﾐSｷI;デﾗヴっ“PくPOPくTOTLいﾉﾗI;デｷﾗﾐゲЭDE ぷAIIWゲゲWS ヱヴ DWIWﾏHWヴ 
ヲヰヱΒへく 
TｴW WﾗヴﾉS B;ﾐﾆく ふヲヰヱΒHぶく Bｷヴデｴ ヴ;デWが Iヴ┌SW ふヮWヴ ヱがヰヰヰ ヮWﾗヮﾉWぶ づ D;デ;く ぷﾗﾐﾉｷﾐWへ A┗;ｷﾉ;HﾉW ;デぎ 
ｴデデヮゲぎっっS;デ;く┘ﾗヴﾉSH;ﾐﾆくﾗヴｪっｷﾐSｷI;デﾗヴっ“PくDYNくCB‘TくINいﾉﾗI;デｷﾗﾐゲЭDE ぷAIIWゲゲWS ヱヴ DWIWﾏHWヴ 
ヲヰヱΒへく 
TｴW WﾗヴﾉS B;ﾐﾆく ふヲヰヱΒIぶく Pﾗヮ┌ﾉ;デｷﾗﾐ SWﾐゲｷデ┞ ふヮWﾗヮﾉW ヮWヴ ゲケく ﾆﾏ ﾗa ﾉ;ﾐS ;ヴW;ぶ づ D;デ;く ぷﾗﾐﾉｷﾐWへ 
A┗;ｷﾉ;HﾉW ;デぎ ｴデデヮゲぎっっS;デ;く┘ﾗヴﾉSH;ﾐﾆくﾗヴｪっｷﾐSｷI;デﾗヴっENくPOPくDN“TいﾉﾗI;デｷﾗﾐゲЭDE ぷAIIWゲゲWS ヱヴ 
DWIWﾏHWヴ ヲヰヱΒへく 
TｴW WﾗヴﾉS B;ﾐﾆく ふヲヰヱΒSぶく Mﾗヴデ;ﾉｷデ┞ ヴ;デWが ｷﾐa;ﾐデ ふヮWヴ ヱがヰヰヰ ﾉｷ┗W Hｷヴデｴゲぶ づ D;デ;く ぷﾗﾐﾉｷﾐWへ A┗;ｷﾉ;HﾉW 
;デぎ ｴデデヮゲぎっっS;デ;く┘ﾗヴﾉSH;ﾐﾆくﾗヴｪっｷﾐSｷI;デﾗヴっ“PくDYNくIM‘TくINいﾉﾗI;デｷﾗﾐゲЭDE ぷAIIWゲゲWS ヱヴ 
DWIWﾏHWヴ ヲヰヱΒへく 
TｴW WﾗヴﾉS B;ﾐﾆく ふヲヰヱΒWぶく LｷaW W┝ヮWIデ;ﾐI┞ ;デ Hｷヴデｴが デﾗデ;ﾉ ふ┞W;ヴゲぶ づ D;デ;く ぷﾗﾐﾉｷﾐWへ A┗;ｷﾉ;HﾉW ;デぎ 
ｴデデヮゲぎっっS;デ;く┘ﾗヴﾉSH;ﾐﾆくﾗヴｪっｷﾐSｷI;デﾗヴっ“PくDYNくLEヰヰくINいﾉﾗI;デｷﾗﾐゲЭDE ぷAIIWゲゲWS ヱヴ DWIWﾏHWヴ 
ヲヰヱΒへく 
TｴW WﾗヴﾉS B;ﾐﾆく ふヲヰヱΒaぶく DW;デｴ ヴ;デWが Iヴ┌SW ふヮWヴ ヱがヰヰヰ ヮWﾗヮﾉWぶ づ D;デ;く ぷﾗﾐﾉｷﾐWへ A┗;ｷﾉ;HﾉW ;デぎ 
ｴデデヮゲぎっっS;デ;く┘ﾗヴﾉSH;ﾐﾆくﾗヴｪっｷﾐSｷI;デﾗヴっ“PくDYNくCD‘TくINいﾉﾗI;デｷﾗﾐゲЭDE ぷAIIWゲゲWS ヱヴ DWIWﾏHWヴ 
ヲヰヱΒへく 




WﾗヴﾉS HW;ﾉデｴ Oヴｪ;ﾐｷゲ;デｷﾗﾐ ふWHOぶく ふヲヰヱヶぶく Cﾗ┌ﾐデヴｷWゲが GWヴﾏ;ﾐ┞く ぷONLINEへ A┗;ｷﾉ;HﾉW ;デぎ 
ｴデデヮぎっっ┘┘┘く┘ｴﾗくｷﾐデっIﾗ┌ﾐデヴｷWゲっSW┌っWﾐっく ぷAIIWゲゲWS ヱヴ DWIWﾏHWヴ ヲヰヱΒへく 
 
